|
|
|
Sunday, March 21, 2010 — 1:30 PM, Thurgood North East
|
- Mimicry in Dermatopathology: Sheep in Wolves' Clothing
|
|
Moderator:
|
Hideko Kamino, New York University School of Medicine, New York, NY
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 1:30 | Mycosis Fungoides-Like Reactions - Jennifer McNiff, Yale University School of Medicine, New Haven, CT |
| 2:00 | Pseudolymphomas - Cynthia Magro, Weill Cornell Medical Center, New York, NY |
| 2:30 | Mimickers of Carcinomas - Thaddeus Mully, University of California San Francisco, San Francisco, CA |
| 3:00 | Break |
| 3:30 | Melanocytic Mimickers of Melanoma - Philip LeBoit, University of California San Francisco, San Francisco, CA |
| 4:00 | Non-Melanocytic Melanoma-Look Alikes - Hideko Kamino, New York University School of Medicine, new York, NY |
| 4:30 | Pseudosarcomatous Reactions - Mark Wick, University of Virginia Medical Center, Charlottesville, VA |
|
The theme of this symposium will address the challenges in the diagnosis of cutaneous reactions and benign proliferations that mimic lymphomas, carcinomas, melanomas and sarcomas. This topic was chosen because of the many challenges that these benign lesions present in the daily sign out of cases. The objective o the program is to present an array of these pseudomalignancies, and to delineate criteria for their correct diagnosis. The participants will learn the morphologic features and the use of immunohistochemistry and molecular diagnostic techniques to help differentiate these benign mimickers from their malignant counterparts.
|
|
|
|
